These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34029877)

  • 1. Diagnostic value of syndecan-4 protein expression in colorectal cancer.
    Jechorek D; Haeusler-Pliske I; Meyer F; Roessner A
    Pathol Res Pract; 2021 Jun; 222():153431. PubMed ID: 34029877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of loss of epithelial syndecan-1 with stage and local metastasis of colorectal adenocarcinomas: an immunohistochemical study of clinically annotated tumors.
    Hashimoto Y; Skacel M; Adams JC
    BMC Cancer; 2008 Jun; 8():185. PubMed ID: 18590537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
    Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
    J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of CASK correlates with progression and poor prognosis of colorectal cancer.
    Wei JL; Fu ZX; Fang M; Zhou QY; Zhao QN; Guo JB; Lu WD; Wang H
    Tumour Biol; 2014 Sep; 35(9):9185-94. PubMed ID: 24927672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syndecan-2 is upregulated in colorectal cancer cells through interactions with extracellular matrix produced by stromal fibroblasts.
    Vicente CM; Ricci R; Nader HB; Toma L
    BMC Cell Biol; 2013 May; 14():25. PubMed ID: 23705906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of syndecan-4 gene silencing by micro RNA interference in anoikis resistant endothelial cells: Syndecan-4 silencing and anoikis resistance.
    Onyeisi JOS; Pernambuco Filho PCA; Mesquita APS; Azevedo LC; Nader HB; Lopes CC
    Int J Biochem Cell Biol; 2020 Nov; 128():105848. PubMed ID: 32927086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syndecan-4 is a maestro of gastric cancer cell invasion and communication that underscores poor survival.
    Poças J; Marques C; Gomes C; Otake AH; Pinto F; Ferreira M; Silva T; Faria-Ramos I; Matos R; Ribeiro AR; Senra E; Cavadas B; Batista S; Maia J; Macedo JA; Lima L; Afonso LP; Ferreira JA; Santos LL; Polónia A; Osório H; Belting M; Reis CA; Costa-Silva B; Magalhães A
    Proc Natl Acad Sci U S A; 2023 May; 120(20):e2214853120. PubMed ID: 37155874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of syndecan-4 silencing on the extracellular matrix remodeling in anoikis-resistant endothelial cells.
    Onyeisi JOS; Nader HB; Lopes CC
    Cell Biol Int; 2024 Jun; 48(6):883-897. PubMed ID: 38591778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparan Sulfate Proteoglycans in Human Colorectal Cancer.
    Vicente CM; da Silva DA; Sartorio PV; Silva TD; Saad SS; Nader HB; Forones NM; Toma L
    Anal Cell Pathol (Amst); 2018; 2018():8389595. PubMed ID: 30027065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syndecan-4 in Tumor Cell Motility.
    Keller-Pinter A; Gyulai-Nagy S; Becsky D; Dux L; Rovo L
    Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34282767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of syndecan gene amplification with metastatic potential and clinical outcomes in carcinomas.
    Kim S; Yang H; Cho S; Jang Y; Han IO; Oh ES
    Am J Physiol Cell Physiol; 2024 Aug; 327(2):C380-C386. PubMed ID: 38953842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
    Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
    Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periostin expression in intra-tumoral stromal cells is prognostic and predictive for colorectal carcinoma via creating a cancer-supportive niche.
    Xu X; Chang W; Yuan J; Han X; Tan X; Ding Y; Luo Y; Cai H; Liu Y; Gao X; Liu Q; Yu Y; Du Y; Wang H; Ma L; Wang J; Chen K; Ding Y; Fu C; Cao G
    Oncotarget; 2016 Jan; 7(1):798-813. PubMed ID: 26556874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and Function of a Disintegrin and Metalloproteinases in Cancer-Associated Fibroblasts of Colorectal Cancer.
    Mochizuki S; Ao T; Sugiura T; Yonemura K; Shiraishi T; Kajiwara Y; Okamoto K; Shinto E; Okada Y; Ueno H
    Digestion; 2020; 101(1):18-24. PubMed ID: 31722362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syndecan-4 Modulates Epithelial Gut Barrier Function and Epithelial Regeneration in Experimental Colitis.
    Fröhling M; Tepasse P; Intemann J; Sambale M; Sherwood J; Paruzel P; Tiemeyer NM; Nowacki TM; Brückner M; Mennigen R; Lügering A; Echtermeyer F; Pap T; Stratis A; Bettenworth D
    Inflamm Bowel Dis; 2018 Nov; 24(12):2579-2589. PubMed ID: 30053064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial but not stromal expression of collagen alpha-1(III) is a diagnostic and prognostic indicator of colorectal carcinoma.
    Wang XQ; Tang ZX; Yu D; Cui SJ; Jiang YH; Zhang Q; Wang J; Yang PY; Liu F
    Oncotarget; 2016 Feb; 7(8):8823-38. PubMed ID: 26741506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of syndecan-4 is related to clinicopathological features and poor prognosis of pancreatic adenocarcinoma.
    Zhu Y; Zheng D; Lei L; Cai K; Xie H; Zheng J; Yu C
    BMC Cancer; 2022 Oct; 22(1):1042. PubMed ID: 36199068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lgr5 over-expression is positively related to the tumor progression and HER2 expression in stage pTNM IV colorectal cancer.
    Gao FJ; Chen JY; Wu HY; Shi J; Chen M; Fan XS; Huang Q
    Int J Clin Exp Pathol; 2014; 7(4):1572-9. PubMed ID: 24817953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syndecan-4 and fibronectin in osteosarcoma.
    Na KY; Bacchini P; Bertoni F; Kim YW; Park YK
    Pathology; 2012 Jun; 44(4):325-30. PubMed ID: 22531343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of TGM2 with ITGB1 and SDC4 is important in the development and metastasis of renal cell carcinoma.
    Erdem M; Erdem S; Sanli O; Sak H; Kilicaslan I; Sahin F; Telci D
    Urol Oncol; 2014 Jan; 32(1):25.e13-20. PubMed ID: 23499501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.